TherapeuticsMD (TXMD): Price Target and June Short Interest Disclosure

TherapeuticsMD (TXMD) : The highest level TherapeuticsMD (TXMD) is projected to reach is $18 for the short term and the lowest estimate is at $13. The consolidated price target from 4 rating analysts who initiate coverage on the stock is $15.63 and the possibility the share price can swing is $2.5.

TherapeuticsMD (TXMD) has seen a rise of 1,631,996 shares or 4.7% in the short interest. The remaining shorts are 23.8% of the total floated shares. The net short interest, as on June 30,2016, stood at 36,718,400 shares and the stocks days to cover will be 23 by factoring in the average per day volume of 1,624,621 shares. On June 15,2016, 35,086,404 shares were shorted. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 12th.

Also, Goldman Sachs initiates coverage on TherapeuticsMD (NYSEMKT:TXMD) The brokerage firm has issued a Buy rating on the shares. The Analysts at the ratings agency announces the price target to $10 per share. The rating by the firm was issued on April 4, 2016.


TherapeuticsMD (NYSEMKT:TXMD): stock turned positive on Thursday. Though the stock opened at $7.64, the bulls momentum made the stock top out at $8.08 level for the day. The stock recorded a low of $7.64 and closed the trading day at $7.94, in the green by 4.34%. The total traded volume for the day was 3,465,585. The stock had closed at $7.61 in the previous days trading.

TherapeuticsMD, Inc. is a womens health care product company. The Company is engaged in creating and commercializing products for women. The Company is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. It manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins. It markets its prescription and OTC prenatal vitamins and other products under its vitaMedMD brand name and duplicate formulations of its prescription prenatal vitamin products, also referred to as generic formulations, under its BocaGreenMD brand name. The Companys products include prenatal vitamins, vitaMedMD Plus Rx, vitaMedMD One Rx, vitaMedMD RediChew Rx and BocaGreenMD Prena1 line of prescription prenatal vitamins, which included three prescription prenatal vitamins that were generic formulations of its vitaMedMD-branded prescription prenatal vitamins.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.